Table 2.
(A) Absolute volumetric reduction (mL) at 1-, 3- and 6-month follow-ups, expressed as median and interquartile range; (B) volume reduction rate (%) at 1-, 3- and 6-month follow-ups, expressed as median and interquartile range
| ATN (n = 18) | FTN (n = 18) | p value | |
|---|---|---|---|
| A | Absolute volumetric reduction (mL) | ||
| 1 month | 6.0 (3.275–7.850) | 5.9 (4.7–8.0) | 0.94 |
| 3 months | 8.90 (6.20–14.12) | 9.4 (7.75–16.48) | 0.85 |
| 6 months | 10.55 (6.175–16.125) | 12.5 (9.65–16.02) | 0.27 |
| B | Volume reduction rate (%) | ||
| 1 month | 33.50 (16.75–55.75) | 29.50 (25.25–46.25) | 0.67 |
| 3 months | 55.50 (30.25–63.75) | 52.00 (45.50–57.50) | 0.80 |
| 6 months | 54.50 (39.00–72.75) | 63.50 (55.00–75.50) | 0.14 |
p values were derived from the Wilcoxon test
ATN adjustable-tip needle, FTN fixed-tip needle